Baxter Gets A Boost From Vaccines And Antivirals
June 20, 2020 at 14:10 PM EDT
While the coronavirus pandemic has reduced the number of elective surgical procedures and impacted the availability of certain materials, Baxter International Inc. has partly offset this impact through its product portfolio, asserts Jasper Hellweg.
